Laddar...
Increase of secondary mutations may be a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor
Objective: To investigate changes in the secondary mutations of tumor in a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor (TKI). Methods: Lung adenocarcinoma cell line PC9 in vitro and xenograft model in nude mice were used to observ...
Sparad:
| I publikationen: | J Cancer |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Ivyspring International Publisher
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6775686/ https://ncbi.nlm.nih.gov/pubmed/31632481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.35247 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|